Copyright
©The Author(s) 2022.
World J Clin Oncol. Apr 24, 2022; 13(4): 287-302
Published online Apr 24, 2022. doi: 10.5306/wjco.v13.i4.287
Published online Apr 24, 2022. doi: 10.5306/wjco.v13.i4.287
Table 2 Positron-emission tomography negative or positive status according to anatomical region of interest and according to tumor size, n (%)
| Anatomical region of interest | Tumor ≤ 20 mm | Tumor > 20 mm | P |
| n = 37 | n = 67 | ||
| Breast ipsilateral | < 0.001 | ||
| PET negative | 12 (32.4) | 5 (7.5) | |
| PET positive | 25 (67.6) | 62 (92.5) | |
| Axillary ipsilateral | 0.006 | ||
| PET negative | 29 (78.4) | 34 (50.7) | |
| PET positive | 8 (21.6) | 33 (49.3) | |
| Sternal | 0.906 | ||
| PET negative | 35 (94.6) | 63 (94.0) | |
| PET positive | 2 (5.4) | 4 (6.0) | |
| Distant | 0.447 | ||
| PET negative | 32 (86.5) | 54 (80.6) | |
| PET positive | 5 (13.5) | 13 (19.4) | |
| Any of axillary or sternal | 0.019 | ||
| PET negative | 27 (73.0) | 33 (49.3) | |
| PET positive | 10 (27.0) | 34 (50.7) | |
| Any of axillary, sternal, or distant | 0.005 | ||
| PET negative | 26 (70.3) | 28 (41.8) | |
| PET positive | 11 (29.7) | 39 (58.2) |
- Citation: Perrin J, Farid K, Van Parijs H, Gorobets O, Vinh-Hung V, Nguyen NP, Djassemi N, De Ridder M, Everaert H. Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer? A 15-year overall survival analysis. World J Clin Oncol 2022; 13(4): 287-302
- URL: https://www.wjgnet.com/2218-4333/full/v13/i4/287.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i4.287